Poseida Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Poseida Therapeutics Inc
TickerPSTX
CIK #0001661460
CUSIP70322H106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address9390 Towne Centre Drive Suite 200, San Diego, CA 92121
Source [EDGAR]
CIK Filing 2011 - 2025
[0001661460] 10-K
[0001661460] 10-Q
[0001661460] 3
[0001661460] 4
[0001661460] 5
[0001661460] 8-K
[0001661460] D
[0001661460] SC 13D
[0001661460] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Novartis Pharma AG Poseida Therapeutics Inc [2021-02-12] 9.6
Malin Life Sciences Holdings Ltd Poseida Therapeutics Inc [2021-02-03] 14.9
Pentwater Capital Management LP Poseida Therapeutics Inc [2020-12-28] 8.03
FMR LLC Poseida Therapeutics Inc [2020-08-10] 0.0
Form 3/4/5 Filer 2011 - 2025
Amado Rafael
Poseida Therapeutics, Inc.
Yarema Kristin
Gergen Mark J
Warner Brent
Mylet Johanna
Leonhardt Harry J
Ostertag Eric
Malin Life Sciences Holdings Ltd
Collins Cynthia
Corning Luke
Schmid John P.
Lloyd Marcea Bland
BAUM Charles M
Ingalls Kerry D.
Spear Matthew A.
Hirsch David
Novartis AG
Novartis Pharma AG
Murphy Sean
Malin Corp plc
Mackey Catherine J
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2023-03-31] DFND 12,979,080.0 12,979,080.0
Pentwater Capital Management LP [2023-03-31] SOLE 5,975,000.0 5,975,000.0
SilverArc Capital Management LLC [2023-03-31] SOLE 2,689,301.0 2,689,301.0
EcoR1 Capital LLC [2023-03-31] SOLE 2,650,000.0 2,650,000.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,302,145.0
BlackRock Inc. [2023-03-31] SOLE 1,868,199.0 1,889,823.0
Paradigm Biocapital Advisors LP [2023-03-31] SOLE 1,072,410.0 1,072,410.0
Aisling Capital Management LP [2023-03-31] SOLE 1,043,267.0 1,043,267.0
Acadian Asset Management LLC [2023-03-31] DFND 1,011,383.0 1,011,383.0
Cormorant Asset Management LP [2023-03-31] DFND 1,000,000.0 1,000,000.0
Millennium Management LLC [2023-03-31] SOLE 975,612.0 975,612.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 672,877.0 695,846.0
Susquehanna International Group LLP [2023-03-31] DFND 651,394.0 651,394.0
Renaissance Technologies LLC [2023-03-31] SOLE 341,031.0 603,200.0
Laurion Capital Management LP [2023-03-31] SOLE 545,700.0 545,700.0
Geode Capital Management LLC [2023-03-31] DFND 506,090.0 506,090.0
Morgan Stanley [2023-03-31] DFND 475,806.0 481,826.0
Two Sigma Investments LP [2023-03-31] SOLE 481,044.0 481,044.0
Marshall Wace LLP [2023-03-31] OTR 0.0 448,745.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 372,285.0
Goldman Sachs Group Inc [2023-03-31] DFND 293,362.0 293,362.0
Cubist Systematic Strategies, LLC [2023-03-31] DFND 0.0 292,721.0
Qube Research & Technologies Ltd [2023-03-31] SOLE 0.0 277,168.0
Citadel Advisors LLC [2023-03-31] DFND 274,704.0 274,704.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 260,746.0 260,746.0
Advisory Services Network LLC [2023-03-31] SOLE 257,271.0 257,271.0
Jane Street Group LLC [2023-03-31] DFND 253,169.0 253,169.0
Bank of America Corp /DE/ [2023-03-31] DFND 0.0 252,148.0
State Street Corp [2023-03-31] DFND 234,467.0 234,467.0
HRT Financial LP [2023-03-31] DFND 191,064.0 191,064.0
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com